NasdaqCM - Nasdaq Real Time Price USD

Wellgistics Health, Inc. (WGRX)

2.3000
+0.5100
+(28.49%)
As of 11:00:24 AM EDT. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Total Revenue
18,128.8310
18,128.8310
0
32,777.7280
Cost of Revenue
16,361.5170
16,361.5170
0
27,028.8740
Gross Profit
1,767.3140
1,767.3140
0
5,748.8540
Operating Expense
7,912.4460
7,912.4460
2,880.6030
9,171.5830
Operating Income
-6,145.1320
-6,145.1320
-2,880.6030
-3,422.7290
Net Non Operating Interest Income Expense
-831.4670
-831.4670
-15.0810
-287.1830
Other Income Expense
120.3730
120.3730
98.1320
966.1120
Pretax Income
-6,856.2260
-6,856.2260
-2,895.6840
-2,743.8000
Tax Provision
0
0
0
0
Net Income Common Stockholders
-6,856.2260
-6,856.2260
-2,895.6840
-2,743.8000
Diluted NI Available to Com Stockholders
-6,856.2260
-6,856.2260
-2,895.6840
-2,743.8000
Basic EPS
-0.15
--
-0.06
-0.06
Diluted EPS
-0.15
--
-0.06
-0.06
Basic Average Shares
47,252.0810
--
44,720
47,252.0810
Diluted Average Shares
47,252.0810
--
44,720
47,252.0810
Total Operating Income as Reported
-6,145.1320
-6,145.1320
-2,880.6030
-3,422.7290
Total Expenses
24,273.9630
24,273.9630
2,880.6030
36,200.4570
Net Income from Continuing & Discontinued Operation
-6,856.2260
-6,856.2260
-2,895.6840
-2,743.8000
Normalized Income
-6,856.2260
-6,856.2260
-2,895.6840
-4,561.8540
Interest Expense
831.4670
831.4670
15.0810
287.1830
Net Interest Income
-831.4670
-831.4670
-15.0810
-287.1830
EBIT
-6,024.7590
-6,024.7590
-2,880.6030
-2,456.6170
EBITDA
-4,910.0950
-4,910.0950
-2,880.6030
-369.0340
Reconciled Cost of Revenue
16,361.5170
16,361.5170
0
27,028.8740
Reconciled Depreciation
1,114.6640
1,114.6640
0
2,087.5830
Net Income from Continuing Operation Net Minority Interest
-6,856.2260
-6,856.2260
-2,895.6840
-2,743.8000
Total Unusual Items Excluding Goodwill
--
--
--
1,818.0540
Total Unusual Items
--
--
--
1,818.0540
Normalized EBITDA
-4,910.0950
-4,910.0950
-2,880.6030
-2,187.0880
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
12/31/2022 - 2/21/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers